Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational study | Synapse
March 3, 2026
Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational study
Key Points
Outpatient parenteral antimicrobial therapy effectively managed infections in immunocompromised hosts, showing promise for treatment.
Key evidence includes a significant reduction in infection rates observed through the real-world data analysis.
This observational study highlights the management of gram-negative bacteria infections in severely immunocompromised individuals.
The findings may enable broader adoption of OPAT as a treatment strategy for complex infections, warranting further research.